Form 4: Lemaitre Vascular Inc. Executive Trent G. Kamke Reports Stock Transactions

Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., reports acquisition and disposal of common stock and dividend equivalent rights related to performance share units.

Summary

• On February 29, 2024, Trent G. Kamke, Senior VP of Operations at Lemaitre Vascular Inc., reported transactions involving the company's common stock.
• Kamke acquired 1,192 shares of common stock upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022.
• He also acquired 3 shares upon release of dividend equivalent rights.
• 86 shares were withheld by the issuer to satisfy tax withholding obligations.
• Following these transactions, Kamke beneficially owns 9,103 shares of Lemaitre Vascular Inc. common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reflects routine transactions related to stock-based compensation. There's no indication of significant positive or negative sentiment towards the company's prospects.

Positives

• The acquisition of shares through PSU vesting suggests the achievement of certain performance goals within the company.

Negatives

• The withholding of shares for tax obligations reduces the net gain from the PSU vesting.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key personnel and their sentiment towards the company's stock.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they involve a small number of shares relative to the company's total outstanding shares.
• Employees holding similar stock-based compensation may be interested in the vesting schedule and tax implications.

Key Dates